High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory pemphigus foliaceus [2]

Bone Marrow Transplantation

Volumn 34, Issue 12, 2004, Pages 1097-1098

  Oyama, Y ^a   Parker, E R ^a   Brieva, J ^a   Guitart, J ^a   Statkute, L ^a   Verda, L ^a   Burt, R K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; FLUCONAZOLE; GOLD DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; MESNA; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; PREDNISONE; TETRACYCLINE; THYMOCYTE ANTIBODY; VALACICLOVIR; VANCOMYCIN;

ADULT; ANOREXIA; ANTIBIOTIC PROPHYLAXIS; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BULLOUS SKIN DISEASE; CASE REPORT; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HISPANIC; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; NAUSEA; OPPORTUNISTIC INFECTION; PEMPHIGUS FOLIACEUS; PLASMAPHERESIS; PRIORITY JOURNAL; PUNCH BIOPSY; STEM CELL MOBILIZATION;

ADULT; AUTOIMMUNE DISEASES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PEMPHIGUS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS;

EID: 11144328248     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704679     Document Type: Letter

References (9)

1. Burt RK, Arnold R, Emmons R et al. A stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting. Bone Marrow Transplant 2003; 32 (Suppl 1): S3-S5.
2. Burt RK, Slavin S, Burns WH, Marmont A. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768-784.
3. Burt RK, Traynor A, Oyama Y, Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood 2003; 101: 2064-2066.
4. Stanley JR, Klaus-Kovtun V, Sampaio SA. Antigenic specificity of fogo selvagem autoantibodies is similar to North American pemphigus foliaceus and distinct from pemphigus vulgaris autoantibodies. J Invest Dermatol 1986; 87: 197-201.
5. Amagai M, Karpati S, Prussick R et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90: 919-926.
6. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976; 112: 962-970.
7. Nousari CH, Brodsky R, Anhalt GJ. Evaluating the role of immunoablative high-dose cyclophosphamide therapy in Pemphigus vulgaris. J Am Acad Dermatol 2003; 49: 148-150.
8. Cohen MA, Cohen JJ, Kerdel FA. Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus focliaceus. Int J Dermatol 2002; 41: 340-344.
9. Hayag MV, Cohen JA, Kerdel FA. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol 2000; 43: 1065-1069.